A highly specialized research team at Seoul National University and RNL Stem Cell Research Institute have been focusing intensive efforts on creating a viable stem cell treatment for Alzheimer’s by 2016.
Alzheimer’s Disease (AD) is the most prevalent neurodegenerative disorder in the UniteStates affecting approximately 5.3 million Americans . AD is characterized by progressive loss in memory and as well as a decline in the ability to learn that is associated with neuronal death.
The research team, led by professor Suh Yoo-hun, has spent the last three years developing an effective therapy using adult stem cells. The project has progressed rapidly as a result of positive findings.
In the current trial, mice suffering from Alzheimer’s were given injections of human adult stem cells. The mice recovered to a nearly full cognitive function. The researchers also reported that “the adult stem cells have preventative effects on potential sufferers of Alzheimer’s”. The research will soon advance to human clinical trials and will utilize the patient’s own [autologous] stem cells.
In human applications, the use of one’s own stem cells is emerging as the gold standard of regenerative therapies. Banking your own stem cells ensures access to the optimal treatment options when families need them most.
To learn how to bank your own valuable stem cells to insure your future health, visit www.stemsave.com or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The future of Regenerative Medicine is now™.